OBJECTIVE. The purpose of the present study is to prospectively compare the capability of dynamic oxygen-enhanced MRI and quantitative CT for pulmonary functional loss assessment and clinical stage classification of smoking-related chronic obstructive pulmonary disease (COPD). SUBJECTS AND METHODS. Ten nonsmoking and 61 consecutive smoking-related COPD subjects underwent dynamic oxygen-enhanced MRI, CT, and pulmonary function tests. COPD subjects were classified into four clinical stages on the basis of the ATS–ERS guidelines. Wash-in time and relative enhancement ratio maps were generated by pixel-by-pixel analyses. Mean wash-in time and relative enhancement ratio were determined as averages of region of interest (ROI) measurements. CT-based functional lung volumes were measured on quantitative CT using the density-masked CT technique. For comparison of assessment capability for smoking-related functional loss, the three parameters were correlated with the percentage predicted forced expiratory volume in 1 second (%FEV1) and the percentage predicted diffusing capacity of the lung for carbon monoxide corrected for alveolar volume (%DLCO/Va). To determine the clinical stage classification capability, these parameters were statistically compared for nonsmoking subjects and all clinical stages of smoking-related COPD subjects. RESULTS. Correlation between mean wash-in time and %FEV1 (r = –0.74, p < 0.0001) and between mean relative enhancement ratio and %DLCO /Va (r = 0.66, p < 0.0001) was better than that between CT-based functional lung volume and either %FEV1 (r = 0.61, p < 0.0001) or %DLCO/Va (r = 0.56, p < 0.0001). Mean wash-in time showed a significant difference between nonsmoking and smoking-related COPD subjects at all clinical stages (p < 0.05). CONCLUSION. Dynamic oxygen-enhanced MRI has potential for pulmonary functional loss assessment and clinical stage classification of smoking-related COPD as does quantitative CT.
23 October 2009 in Journal of Magnetic Resonance Imaging
Purpose: To compare the utility of phase contrast MR imaging (PC‐MRI) for assessment of pulmonary flow and pressure estimation with that of right heart catheterization and echocardiography (cardiac US) in patients with pulmonary arterial hypertension (PAH). Materials and Methods: Twenty consecutive patients with suspected PAH underwent PC‐MRI, cardiac US, and right heart catheterization. In each patient, PC‐MRI was acquired by cine 2D‐PC method on a 1.5 Tesla scanner, and stroke volume (SV) and pulmonary arterial systolic pressure (PASP) were assessed by using the modified Bernoulli's equation. To evaluate the agreements of SV and PASP among the three methods, correlations and limits of agreement among the three methods were statistically assessed by using the Bland‐Altman's analyses. Results: The correlations and limits of agreement for SV and PASP between PC‐MRI and catheterization (r = 0.96, r2 = 0.94, 1.1 ± 6.9 mL and r = 0.94, r2 = 0.88, −3.2 ± 14.5 mmHg, respectively) were better than between cardiac US and catheterization (r = 0.01, r2 < 0.01, 8.9 ± 42.1 mL and r = 0.86, r2 = 0.72, −5.9 ± 27.7 mmHg, respectively). Conclusion: PC‐MRI is more compatible with right heart catheterization than cardiac US in pulmonary flow and pressure estimation. J. Magn. Reson. Imaging 2009;30:973–980.